Lv1
55 积分 2021-05-17 加入
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial
12天前
已完结
JAK inhibitors in difficult-to-treat adult-onset Still’s disease and systemic-onset juvenile idiopathic arthritis
13天前
已完结
JAK inhibitors in systemic juvenile idiopathic arthritis
13天前
已完结
Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial
27天前
已完结
Updates on efficacy and safety janus kinase inhibitors in juvenile dermatomyositis
2个月前
已完结
Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
5个月前
已完结
Recent Advancements in Computed Tomography Assessment of Fibrotic Interstitial Lung Diseases
1年前
已完结
The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis
1年前
已完结
Relative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in comparison to adalimumab in patients with active rheumatoid arthritis
1年前
已完结
Impact of Sn doping on methylammonium lead chloride perovskite: An experimental study
皖公网安备34019202002308
